|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| RZLT | KREHER NERISSA | Director | Jun 13 '25 | Buy | 3.25 | 3,076 | 9,997 | 37,576 | Jun 23 09:12 AM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 06 '23 | Sale | 13.48 | 892 | 12,022 | 40,037 | Sep 06 05:08 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Aug 04 '23 | Option Exercise | 2.10 | 6,898 | 14,486 | 34,028 | Aug 04 04:50 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Aug 02 '23 | Option Exercise | 2.10 | 10,348 | 21,731 | 37,478 | Aug 04 04:50 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Aug 03 '23 | Option Exercise | 2.10 | 9,464 | 19,874 | 36,594 | Aug 04 04:50 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Aug 02 '23 | Sale | 15.19 | 10,348 | 157,168 | 27,130 | Aug 04 04:50 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Aug 04 '23 | Sale | 14.14 | 6,898 | 97,521 | 27,130 | Aug 04 04:50 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Aug 03 '23 | Sale | 14.74 | 9,464 | 139,530 | 27,130 | Aug 04 04:50 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Mar 02 '23 | Sale | 10.56 | 1,641 | 17,336 | 41,330 | Mar 03 04:32 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Dec 30 '22 | Sale | 13.45 | 5,200 | 69,932 | 15,516 | Jan 03 04:32 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Oct 25 '22 | Option Exercise | 2.10 | 8,040 | 16,884 | 28,756 | Oct 27 06:49 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Oct 26 '22 | Option Exercise | 2.10 | 4,960 | 10,416 | 25,676 | Oct 27 06:49 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Oct 26 '22 | Sale | 21.91 | 4,960 | 108,659 | 20,716 | Oct 27 06:49 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Oct 25 '22 | Sale | 20.88 | 8,040 | 167,890 | 20,716 | Oct 27 06:49 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 27 '22 | Option Exercise | 2.10 | 2,403 | 5,046 | 23,119 | Sep 28 05:10 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 28 '22 | Option Exercise | 2.10 | 3,122 | 6,556 | 23,838 | Sep 28 05:10 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 26 '22 | Option Exercise | 2.10 | 3,068 | 6,443 | 23,784 | Sep 28 05:10 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 26 '22 | Sale | 15.33 | 3,068 | 47,030 | 20,716 | Sep 28 05:10 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 28 '22 | Sale | 15.25 | 3,122 | 47,610 | 20,716 | Sep 28 05:10 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 27 '22 | Sale | 15.31 | 2,403 | 36,789 | 20,716 | Sep 28 05:10 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 21 '22 | Option Exercise | 2.10 | 3,341 | 7,016 | 24,057 | Sep 23 04:57 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 23 '22 | Option Exercise | 2.10 | 939 | 1,972 | 21,655 | Sep 23 04:57 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 23 '22 | Sale | 15.09 | 939 | 14,167 | 20,716 | Sep 23 04:57 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 21 '22 | Sale | 15.08 | 3,341 | 50,393 | 20,716 | Sep 23 04:57 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 15 '22 | Option Exercise | 2.10 | 106 | 223 | 20,822 | Sep 19 04:32 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 15 '22 | Sale | 15.01 | 106 | 1,591 | 20,716 | Sep 19 04:32 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 08 '22 | Option Exercise | 2.10 | 1,221 | 2,564 | 21,937 | Sep 12 04:18 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 09 '22 | Option Exercise | 2.10 | 800 | 1,680 | 21,516 | Sep 12 04:18 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 09 '22 | Sale | 15.07 | 800 | 12,054 | 20,716 | Sep 12 04:18 PM |
| TRDA | KREHER NERISSA | Chief Medical Officer | Sep 08 '22 | Sale | 15.13 | 1,221 | 18,478 | 20,716 | Sep 12 04:18 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite